Venari Medical announces publication of pre-clinical data in

/PRNewswire/ -- InVera Medical are delighted to announce the publication of its pre-clinical feasibility study of the InVera minimally invasive, exclusively

Venari Medical announces publication of pre-clinical data in leading scientific journal Phlebology and changes name to InVera Medical™

Nerviano Medical Sciences S.r.l. to Present Preliminary Phase 1 PARP1 selective inhibitor data at the 35th AACR-NCI-EORTC 2023: Poster - Nerviano Medical Sciences

Bridging clinical and real-world data

Venari Medical announces publication of pre-clinical data in leading scientific journal Phlebology and changes name to InVera Medical™

How to stimulate big ideas in healthcare

g869617.jpg

Latest news – Forest Devices

Earlybird Venture Capital on LinkedIn: #ebvchealth #ebvclive #tbchcambridge #techbio #startups #networking

TechFem Fridays - New foetal abnormality tests, workplace-supporting women's health companies & Natural Cycles in the spotlight

Vena Medical Announces Publication of Pre-Clinical Study — OBIO - Ontario Bioscience Innovation Organization